Alexza Pharmaceuticals

Alexza Pharmaceuticals, located in Mountain View, CA, is focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's products are based on the Staccato system, a hand-held inhaler designed to deliver a drug aerosol to the deep lung, providing rapid systemic delivery and therapeutic onset, in a simple, non-invasive manner. ADASUVE is the first and only inhalation therapy for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder. ADASUVE combines Alexza’s proprietary Staccato system with loxapine, an antipsychotic medicinal product. The Staccato system is a hand-held inhaler that delivers a drug aerosol to the deep lung that results in intravenous-like pharmacokinetics and rapid systemic effects. Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., is Alexza's commercial partner for ADASUVE in the United States. Grupo Ferrer Internacional SA is Alexza's commercial partner for ADASUVE in Europe, Latin America and the Commonwealth of Independent States countries. ADASUVE® and Staccato® are registered trademarks of Alexza Pharmaceuticals, Inc.
Show more

Employee Rating

3.7More
TypeSubsidiary
HQMountain View, CA, US
Founded2001
Websitealexza.com
Cybersecurity ratingAMore
Alexza Pharmaceuticals was founded in 2001 and is headquartered in Mountain View, CA, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Alexza Pharmaceuticals

Leighton Read

Leighton Read

Director
Darl Moreland

Darl Moreland

Vice President, Quality
Show more

Alexza Pharmaceuticals Office Locations

Alexza Pharmaceuticals has an office in Mountain View
Mountain View, CA, US (HQ)
2091 Stierlin Ct
Show all (1)

Alexza Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2001

Total Funding

$178.9 m

Investors

In total, Alexza Pharmaceuticals had raised $178.9 m

Alexza Pharmaceuticals Revenue

Alexza Pharmaceuticals's revenue was reported to be $2.67 m in FY, 2015 which is a 9.6% decrease from the previous period.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Revenue

5.7m4.1m47.8m3.0m2.7m

Revenue growth, %

(88%)(10%)

Cost of goods sold

11.2m15.9m21.1m

Gross profit

36.6m(12.9m)(18.5m)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016

Revenue

1.3m1.3m1.9m728.0k729.0k729.0k43.6m2.2m1.7m368.0k364.0k618.0k1.9m1.8m720.0k

Cost of goods sold

3.0m4.0m3.8m4.9m3.3m6.1m4.1m3.7m945.0k

Gross profit

40.7m(1.8m)(2.1m)(4.5m)(2.9m)(5.5m)(2.3m)(1.9m)(225.0k)

Gross profit Margin, %

93%(82%)(119%)(1232%)(801%)(895%)(120%)(107%)(31%)
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Cash

14.9m17.7m17.3m15.2m7.8m

Accounts Receivable

10.0m129.0k173.0k

Prepaid Expenses

649.0k852.0k1.5m3.1m3.2m

Inventories

3.4m3.7m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016

Cash

15.9m10.5m24.4m18.5m25.5m11.7m25.9m23.8m53.1m10.5m11.6m11.1m12.2m11.3m4.5m

Accounts Receivable

106.0k25.0k278.0k1.0m1.0m99.0k303.0k822.0k8.0k

Prepaid Expenses

721.0k886.0k912.0k522.0k766.0k508.0k878.0k1.8m2.4m2.9m3.0m2.2m1.6m1.2m2.9m

Inventories

443.0k1.3m2.1m4.4m4.0m4.4m2.5m1.4m103.0k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Net Income

(40.5m)(28.0m)(39.6m)(36.7m)(21.3m)

Depreciation and Amortization

4.4m4.3m3.3m3.4m3.0m

Inventories

(3.4m)(282.0k)2.5m

Accounts Payable

822.0k(1.5m)1.6m(2.0m)(1.4m)
USDQ2, 2011

Financial Leverage

5.3 x
Show all financial metrics

Alexza Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Alexza Pharmaceuticals Online and Social Media Presence

Embed Graph

Alexza Pharmaceuticals Frequently Asked Questions

  • When was Alexza Pharmaceuticals founded?

    Alexza Pharmaceuticals was founded in 2001.

  • Who are Alexza Pharmaceuticals key executives?

    Alexza Pharmaceuticals's key executives are Leighton Read and Darl Moreland.

  • How many employees does Alexza Pharmaceuticals have?

    Alexza Pharmaceuticals has 81 employees.

  • What is Alexza Pharmaceuticals revenue?

    Latest Alexza Pharmaceuticals annual revenue is $2.7 m.

  • What is Alexza Pharmaceuticals revenue per employee?

    Latest Alexza Pharmaceuticals revenue per employee is $33 k.

  • Who are Alexza Pharmaceuticals competitors?

    Competitors of Alexza Pharmaceuticals include Teva, Takeda and KRKA.

  • Where is Alexza Pharmaceuticals headquarters?

    Alexza Pharmaceuticals headquarters is located at 2091 Stierlin Ct, Mountain View.

  • Where are Alexza Pharmaceuticals offices?

    Alexza Pharmaceuticals has an office in Mountain View.

  • How many offices does Alexza Pharmaceuticals have?

    Alexza Pharmaceuticals has 1 office.